C07C 255 - Carboxylic acid nitriles

Patents for C07C 255 - Carboxylic acid nitriles (27,066)
12/2004
12/02/2004	US20040242913 A aromatic cyanoamide compound; pesticides; veterinary medicine
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242684 Method and compositions for inhibiting cell proliferative disorders
12/02/2004	US20040242652 Beta benzyloxyaspartate derivatives with amino group on benzene ring
12/02/2004	US20040242563 potent, selective and safe inhibitors of Ca2+-activated potassium channel (Gardos channel) of erythrocytes, particularly sickle erythrocytes, and/or of mammalian cell proliferation for treating or preventing cancer, blood vessel proliferative disorders, fibrotic disorders and arteriosclerotic conditions
12/02/2004	US20040242410 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same
12/01/2004	EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004	EP1481244A2 Monomers and polymers having energy absorbing moieties of use in desorption/ionization of analytes
12/01/2004	EP1351921B1 Novel 1,4-diamino-2-alkenyl-benzene derivatives and colorants containing said compounds
12/01/2004	EP1200394A4 Process for preparing acids via alpha-chloroepoxy esters
12/01/2004	EP1073627B1 Processes for preparing pesticidal intermediates
12/01/2004	EP1019190B1 Catalyst comprising at least one phosphonite ligand based nickel (o) complex and method for the production of nitriles
12/01/2004	CN1550497A Preparation of citalopram
12/01/2004	CN1550492A Method for preparing high-purity acetonitrile
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
11/2004
11/30/2004	US6825380 Promoted multi-metal oxide catalyst
11/30/2004	US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/30/2004	US6825043 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds
11/30/2004	US6824890 Topological strategy for designing amorphous molecular solids for forming thin films in optoelectronic devices
11/30/2004	CA2365859C 4-cyano-3-hydroxy butanoyl hydrazines, derivatives and process for the preparation thereof
11/25/2004	WO2004101567A1 2-SUBSTITUTED PHENYL -6,8-DIALKYL-3H-IMIDAZOLE [1,5a][1,3,5] TRIAZINE -4- ONE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF
11/25/2004	WO2004101500A1 Algicidal compound
11/25/2004	WO2004101499A1 Process for producing (meth)acrylonitrile
11/25/2004	WO2004101498A2 Method for the hydrocyanation of unsaturated compounds
11/25/2004	WO2004101497A2 Dinitrile preparation method
11/25/2004	WO2004101136A2 Fluidized bed reactor with gas cooler
11/25/2004	WO2004084842A3 Inhibitors of cathepsin s
11/25/2004	US20040236148 Ferulic acid dimers and their pharmaceutically acceptable salts, their preparation and use thereof for treating dementia
11/25/2004	US20040236137 A carbonyloxycyano compound; pesticides; veterinary medicine
11/25/2004	US20040236131 from aqueous solution or vapor streams of wastes or by-products; contacting with electrophilic compound ; separation
11/25/2004	US20040236129 Optically active catalysts
11/25/2004	US20040236085 Solid-phase nucleophilic fluorination
11/25/2004	US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040235648 chelating phosphonites for use as ligands in transition metal complexes, such as nickel; for use as isomerization catalysts
11/25/2004	US20040235124 Process for production of optically active 3-hydroxy-pentanenitrile
11/25/2004	CA2522674A1 Fluidized bed reactor with gas cooler
11/24/2004	EP1479438A1 Method for the oxidative dehydrogenation of ethane
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004	CN1548438A 2-substituted phenyl-6,8-dialkyl-3H-imidazolyl [1,5 alpha] [1,3,5]-trizin-4-one derivative and its prepn and medicine use
11/24/2004	CN1176905C Ethylglycinate phthalic nitrile as well as its synthetic method and application
11/24/2004	CN1176646C Photo-stable cosmetic and pharmaceutical formulations containing UV-filters
11/23/2004	US6822110 CaO-catalyzed preparation of isophoronenitrile
11/23/2004	US6822101 Reacting 1-(3-butynyl)-pyrrolidine or -piperidine with phenolic compound; cyclization; treating with boronic acid derivative; histamine-3 receptor ligands
11/23/2004	US6821973 Compounds
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/18/2004	WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	WO2004099123A1 Process for producing (meth) acrylonitrile
11/18/2004	WO2004099113A1 Process for converting a hydrocarbon to an oxygenate or a nitrile
11/18/2004	US20040230071 Process for the carbonylation of pentenenitrile
11/18/2004	US20040230070 Catalyst for selective oxidation and amoxidation of alkanes and/or alkenes, particularly in processes for obtaining acrylic acid, acrylonitrile and the derivatives thereof
11/18/2004	US20040229955 Antibacterial agents
11/18/2004	US20040229949 New 3-aryl propionic acid derivatives and analogs
11/18/2004	US20040229946 Antidiabetic agents
11/18/2004	US20040229910 Therapeutic compounds
11/18/2004	CA2523235A1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1476420A1 Ammoxidation of hydrocarbons and hydrogenated metallo oxynitride catalysts therefor
11/17/2004	EP1087953B1 Nitrate salts of antihypertensive medicines
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/17/2004	CN1546463A Method for reducing benzyl alcohol in benzyl cyanide
11/17/2004	CN1176104C Process for preparation of acetyl-guanylphenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/17/2004	CN1176064C Method for preparing aminonitrile and diamine
11/16/2004	US6818660 Calcilytic compounds
11/16/2004	US6818588 NOx treated mixed metal oxide catalyst
11/16/2004	US6818327 Organic electroluminescence device
11/16/2004	CA2236117C Process for producing optically active cyanohydrins
11/16/2004	CA2092306C Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
11/11/2004	WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004	US20040225156 Catalytic hydrogenation of 3-cyano-3,5,5,trimethylcyclohexanone using ammonia and hydrogen; hydrogenation catalyst containing alkali metal oxide with oxides of cobalt , manganese and phosphorous
11/11/2004	US20040225123 Substituted phenyl naphthalenes as estrogenic agents
11/11/2004	US20040225109 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/11/2004	US20040222078 Recycle of condensed quench overheads in a process for purifying acrylonitrile
11/11/2004	DE10323803A1 Verfahren zur Isomerisierung von cis-2-Pentennitril zu trans-3-Pentennitril A process for the isomerization of cis-2-pentenenitrile to trans-3-pentenenitrile
11/10/2004	EP1475369A1 Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these
11/10/2004	EP1474405A2 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
11/10/2004	EP1474382A1 Method for producing substituted 3-phenylamino-propane-1,2-diols
11/10/2004	EP1474380A2 4-dedimethylamino tetracycline compounds
11/10/2004	EP1474127A1 Biphenyl derivatives and their use as antiandrogenic agents
11/10/2004	EP1163051B1 Catalyst comprising a rhodium complex based on a phosphinamidite ligand and its use for hydroformylation
11/10/2004	EP1085009B1 Indan derivatives
11/10/2004	EP1077930B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/10/2004	EP1062200B1 Aminonitrile production
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004	CN1545741A Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/10/2004	CN1545500A Carbonyloxy-cyanomethyl compounds as antiparasitic agents
11/10/2004	CN1545499A Improved operation of head fraction column in acrylonitrile production
11/10/2004	CN1545498A Synthesis of unsaturated nitriles from lactones
11/10/2004	CN1174955C 3-amino-2-benzyl-1-phenyl-propane derivs.
11/10/2004	CN1174801C Catalyst for vapor-phase catalytic oxidation or vapor-phase catalytic ammoxidation of propane or isobutane
11/09/2004	US6815563 Method for producing bicyclic 1,3-diketones
11/09/2004	US6815398 Pre- and postemergence herbicides
11/09/2004	US6815090 Organic electroluminescence device
11/04/2004	WO2004094442A2 Asymmetric catalysts prepared from optically active bisphosphites bridged by achiral diols
11/04/2004	WO2004094364A1 Method for the isomerization of cis-2-pentenenitrile to form trans-3-pentenenitrile
11/04/2004	WO2004094343A1 NOVEL PROCESS FOR STEREOSELECTIVE REDUCTION OF ß-KETOESTERS
11/04/2004	WO2004093799A2 Thyroid receptor ligands
11/04/2004	WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004	WO2003077847A3 Substituted amides

1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 271